Literature DB >> 22179632

Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.

T Piardi1, F Gheza, B Ellero, M L Woehl-Jaegle, D Ntourakis, M Cantu, E Marzano, M Audet, P Wolf, Patrick Pessaux.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is an indication for liver resection or transplantation (LT). In most centers, patients whose HCC meets the Milan criteria are considered for LT. The first objective of this study was to analyze whether there is a correlation between the pathologic characteristics of the tumor, survival and recurrence rate. Second, we focused our attention on vascular invasion (VI).
METHODS: From January 1997 to December 2007, a total of 196 patients who had a preoperative diagnosis of HCC were included. The selection criteria for LT satisfied both the Milan and the San Francisco criteria (UCSF). Demographic, clinical, and pathologic information were recorded.
RESULTS: HCC was confirmed in 168 patients (85.7%). The median follow-up was 74 months. The pathologic findings showed that 106 patients (54.1%) satisfied the Milan criteria, 134 (68.4%) the UCSF criteria of whom 28 (14.3%) were beyond the Milan criteria but within the UCSF criteria, and 34 (17.3%) beyond the UCSF criteria. VI was detected in 41 patients (24%). The 1-, 3-, and 5-year overall survival rates were 90%, 85%, and 77%, respectively, according to the Milan criteria and 90%, 83%, and 76%, respectively, according to the UCSF criteria (P = NS). In univariate and multivariate analyses, tumor size and VI were significant prognostic factors affecting survival (P < 0.001). Two factors were significantly associated with VI: alfa-fetoprotein level of >400 ng/ml and tumor grade G3.
CONCLUSIONS: Tumor size and VI were the only significant prognostic factors affecting survival of HCC patients. Primary liver resection could be a potential selection treatment before LT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22179632     DOI: 10.1245/s10434-011-2170-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  12 in total

1.  Microvascular infiltration has limited clinical value for treatment and prognosis in hepatocellular carcinoma.

Authors:  Nazario Portolani; Gian Luca Baiocchi; Sarah Molfino; Anna Benetti; Federico Gheza; Stefano Maria Giulini
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

2.  A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma.

Authors:  Tsung-Han Wu; Etsuro Hatano; Kenya Yamanaka; Satoru Seo; Kojiro Taura; Kentaro Yasuchika; Yasuhiro Fujimoto; Takashi Nitta; Masaki Mizumoto; Akira Mori; Hideaki Okajima; Toshimi Kaido; Shinji Uemoto
Journal:  Surg Today       Date:  2016-03-16       Impact factor: 2.549

3.  The role of liver transplantation or resection for patients with early hepatocellular carcinoma.

Authors:  Kuan-Chun Hsueh; Ting-Ying Lee; Chew-Teng Kor; Tsung-Ming Chen; Tzu-Ming Chang; Shun-Fa Yang; Chung-Bao Hsieh
Journal:  Tumour Biol       Date:  2015-10-22

Review 4.  Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients.

Authors:  Xiang-Qian Gu; Wei-Ping Zheng; Da-Hong Teng; Ji-San Sun; Hong Zheng
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

5.  Comparison between Milan and UCSF criteria for liver transplantation in patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Jorge Henrique Bento de Sousa; Igor Lepski Calil; Francisco Tustumi; Douglas da Cunha Khalil; Guilherme Eduardo Gonçalves Felga; Rafael Antonio de Arruda Pecora; Marcio Dias de Almeida
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05

Review 6.  Hepatocellular Carcinoma in Liver Cirrhosis: Surgical Resection versus Transarterial Chemoembolization-A Meta-Analysis.

Authors:  Teodor Kapitanov; Ulf P Neumann; Maximilian Schmeding
Journal:  Gastroenterol Res Pract       Date:  2015-01-06       Impact factor: 2.260

7.  The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer.

Authors:  Michał Grąt; Karolina M Wronka; Jan Stypułkowski; Emil Bik; Maciej Krasnodębski; Łukasz Masior; Zbigniew Lewandowski; Karolina Grąt; Waldemar Patkowski; Marek Krawczyk
Journal:  Ann Surg Oncol       Date:  2016-08-16       Impact factor: 5.344

8.  Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinoma.

Authors:  Xiu-Tao Fu; Ying-Hong Shi; Jian Zhou; Yuan-Fei Peng; Wei-Ren Liu; Guo-Ming Shi; Qiang Gao; Xiao-Ying Wang; Kang Song; Jia Fan; Zhen-Bin Ding
Journal:  Infect Agent Cancer       Date:  2017-05-25       Impact factor: 2.965

9.  Limitations of predicting microvascular invasion in patients with hepatocellular cancer prior to liver transplantation.

Authors:  Michał Grąt; Jan Stypułkowski; Waldemar Patkowski; Emil Bik; Maciej Krasnodębski; Karolina M Wronka; Zbigniew Lewandowski; Michał Wasilewicz; Karolina Grąt; Łukasz Masior; Joanna Ligocka; Marek Krawczyk
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

10.  Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Deep Learning: A Multi-Center and Prospective Validation Study.

Authors:  Jingwei Wei; Hanyu Jiang; Mengsu Zeng; Meiyun Wang; Meng Niu; Dongsheng Gu; Huanhuan Chong; Yanyan Zhang; Fangfang Fu; Mu Zhou; Jie Chen; Fudong Lyv; Hong Wei; Mustafa R Bashir; Bin Song; Hongjun Li; Jie Tian
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.